Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic.

Adriana Sarmiento ClementeSheldon L KaplanWilliam J BarsonPhilana Ling LinJosé R RomeroJohn S BradleyTina Q TanPia S PannarajLaurence B GivnerKristina G Hultén

Published in: Journal of the Pediatric Infectious Diseases Society (2022)

Measures to limit SARS-CoV-2 transmission in 2020 reduced other viral infections. Among 7 US children's hospitals, invasive pneumococcal disease cumulative incidence decreased by 46% in 2020 vs 2017-2019. Limited droplet transmission of pneumococci and preceding viral pathogens may be responsible.

Keyphrases

sars cov
respiratory syndrome coronavirus
healthcare
young adults
risk factors
high throughput
single cell
antimicrobial resistance